News Image

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

Provided By GlobeNewswire

Last update: Aug 1, 2025

CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule (IPPS) for fiscal year (FY) 2026, the Centers for Medicare & Medicaid Services (CMS) granted New Technology Add-On Payment (NTAP) reimbursement to cervical fusion procedures using the company’s aprevo® personalized interbody implants.

Read more at globenewswire.com

CARLSMED INC

NASDAQ:CARL (11/21/2025, 8:15:32 PM)

After market: 12.49 0 (0%)

12.49

+0.67 (+5.67%)



Find more stocks in the Stock Screener

CARL Latest News and Analysis

Follow ChartMill for more